GN Store Nord (GN) M&A announcement summary
Event summary combining transcript, slides, and related documents.
M&A announcement summary
8 Jul, 2026Deal rationale and strategic fit
Sale of the Hearing business to Amplifon for DKK 17 billion creates a global leader in audiology and enables a sharper focus on technology innovation in enterprise, gaming, and audio/video peripherals.
The transaction followed unsolicited offers, with Amplifon's proposal deemed most compelling after thorough evaluation.
The deal transforms the seller into a focused technology company, unlocking balance sheet strength for future investments and shareholder returns.
Amplifon aims to preserve and enhance the acquired business's unique identity and strengths.
Board and executive management unanimously approved the deal, considering it in the best long-term interest of shareholders and the business.
Financial terms and conditions
Total consideration is DKK 17 billion, including DKK 12.6 billion in cash and 56 million Amplifon shares valued at DKK 4.4 billion based on recent share price.
Seller will retain about 16% ownership in Amplifon and receive a board seat post-closing, subject to lock-up.
Hearing business generated DKK 7,214 million revenue and DKK 1,185 million pro-forma EBITDA in 2025.
Initial proceeds of DKK 12.6 billion will exceed current net interest-bearing debt of DKK 8.6 billion.
The transaction is taxable, but specific tax liabilities are not disclosed.
Synergies and expected cost savings
Previous integration efforts yielded DKK 600 million in synergies, mainly from supply chain and operations improvements.
The combination leverages over 700 R&D professionals and 2,800 patents, enhancing innovation and clinical expertise.
Integration of R&D, manufacturing, and commercial networks to drive innovation and efficiency.
Combined entity expected to deliver comprehensive solutions and create significant long-term value for stakeholders.
Healthy synergies remain across Enterprise, Gaming, and FalCom, especially in supply chain and some R&D.
Latest events from GN Store Nord
- Q1 organic revenue fell 3%, but new launches and cost actions support cautious 2025 guidance.GN
Q1 20258 Jul 2026 - Hearing sale announced; EBITA margin drops, cost savings and 2026 growth targeted.GN
Q1 20267 May 2026 - Guiding for 3%-7% organic growth and margin expansion in 2026, led by innovation and cost control.GN
Q4 20255 Feb 2026 - Pursuing margin expansion and growth through innovation in hearing, enterprise, and gaming.GN
SEB Nordic Seminar presentation5 Feb 2026 - 5% organic growth and margin gains, with strong Hearing and Gaming, guidance confirmed.GN
Q2 202423 Jan 2026 - Record cash flow and margin gains as Hearing outperformed, offsetting mixed divisional growth.GN
Q3 202416 Jan 2026 - Strong EBITDA growth, new board members, and strategic focus on innovation and resilience.GN
AGM 202520 Dec 2025 - Strong 2024 growth and margin gains set the stage for further expansion in 2025.GN
Q4 202417 Dec 2025 - EBITA up 46% on margin gains, with Hearing strong and 2025 guidance narrowed amid tariff risks.GN
Q2 202523 Nov 2025